Device Diagnostics

Panther Fusion

Payments companies reported to CMS as associated with Panther Fusion. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$20Kassociated payments (2023-2025)
136clinicians with associated payments
2companies reporting

By year

2023 $4,600
2024 $7,269
2025 $7,893

Payments reported as associated with Panther Fusion, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Anatomic Pathology & Clinical Pathology $15K
Molecular Genetic Pathology (Pathology) $1,203
Clinical Pathology $800
Obstetrics & Gynecology $772
Infectious Disease $427
Internal Medicine $413

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Panther Fusion

These are the largest totals companies reported as associated with Panther Fusion. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Benjamin Bradley Salt Lake City, UT Anatomic Pathology & Clinical Pathology $5,904.52
Weihua Tang Hiram, GA Anatomic Pathology & Clinical Pathology $1,512.81
Michael Icardi Iowa City, IA Anatomic Pathology & Clinical Pathology $1,511.82
Jami Skrade Springfield, MO Anatomic Pathology & Clinical Pathology $1,342.92
Charles Sailey Vancouver, WA Molecular Genetic Pathology (Pathology) $1,202.70
Evan Raps Salt Lake City, UT Anatomic Pathology & Clinical Pathology $893.58
Jamie Shutter Las Vegas, NV Anatomic Pathology & Clinical Pathology $841.00
Grace Moore Louisville, KY Anatomic Pathology & Clinical Pathology $812.99
Stacy Beal Dallas, TX Clinical Pathology $760.82
Anne Ruch Maumee, OH Obstetrics & Gynecology $599.37

Prescribed Panther Fusion?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.